Slagle-Webb B - Search Results

1

Common Mutation in the HFE Gene Modifies Recovery After Intracerebral Hemorrhage.

Helmuth TB, Kumari R, Palsa K, Neely EB, Slagle-Webb B, Simon SD, Connor JR. Helmuth TB, et al. Among authors: slagle webb b. Stroke. 2023 Nov;54(11):2886-2894. doi: 10.1161/STROKEAHA.123.043799. Epub 2023 Sep 26. Stroke. 2023. PMID: 37750297 Free PMC article.

2

Cellular iron status influences the functional relationship between microglia and oligodendrocytes.

Zhang X, Surguladze N, Slagle-Webb B, Cozzi A, Connor JR. Zhang X, et al. Glia. 2006 Dec;54(8):795-804. doi: 10.1002/glia.20416. Glia. 2006. PMID: 16958088

3

Interleukin-13 receptor-targeted nanovesicles are a potential therapy for glioblastoma multiforme.

Madhankumar AB, Slagle-Webb B, Mintz A, Sheehan JM, Connor JR. Madhankumar AB, et al. Mol Cancer Ther. 2006 Dec;5(12):3162-9. doi: 10.1158/1535-7163.MCT-06-0480. Mol Cancer Ther. 2006. PMID: 17172420

4

Ferritin: a novel mechanism for delivery of iron to the brain and other organs.

Fisher J, Devraj K, Ingram J, Slagle-Webb B, Madhankumar AB, Liu X, Klinger M, Simpson IA, Connor JR. Fisher J, et al. Am J Physiol Cell Physiol. 2007 Aug;293(2):C641-9. doi: 10.1152/ajpcell.00599.2006. Epub 2007 Apr 25. Am J Physiol Cell Physiol. 2007. PMID: 17459943 Free article.

5

Tim-2 is the receptor for H-ferritin on oligodendrocytes.

Todorich B, Zhang X, Slagle-Webb B, Seaman WE, Connor JR. Todorich B, et al. J Neurochem. 2008 Dec;107(6):1495-505. doi: 10.1111/j.1471-4159.2008.05678.x. Epub 2008 Nov 5. J Neurochem. 2008. PMID: 19014383 Free article.

6

Efficacy of interleukin-13 receptor-targeted liposomal doxorubicin in the intracranial brain tumor model.

Madhankumar AB, Slagle-Webb B, Wang X, Yang QX, Antonetti DA, Miller PA, Sheehan JM, Connor JR. Madhankumar AB, et al. Mol Cancer Ther. 2009 Mar;8(3):648-54. doi: 10.1158/1535-7163.MCT-08-0853. Epub 2009 Mar 10. Mol Cancer Ther. 2009. PMID: 19276162

7

HFE polymorphisms influence the response to chemotherapeutic agents via induction of p16INK4A.

Lee SY, Liu S, Mitchell RM, Slagle-Webb B, Hong YS, Sheehan JM, Connor JR. Lee SY, et al. Int J Cancer. 2011 Nov 1;129(9):2104-14. doi: 10.1002/ijc.25888. Epub 2011 Apr 7. Int J Cancer. 2011. PMID: 21190189 Free article.

8

Heavy chain ferritin siRNA delivered by cationic liposomes increases sensitivity of cancer cells to chemotherapeutic agents.

Liu X, Madhankumar AB, Slagle-Webb B, Sheehan JM, Surguladze N, Connor JR. Liu X, et al. Cancer Res. 2011 Mar 15;71(6):2240-9. doi: 10.1158/0008-5472.CAN-10-1375. Epub 2011 Mar 8. Cancer Res. 2011. PMID: 21385903

9

Characterization of a novel anti-cancer compound for astrocytomas.

Lee SY, Slagle-Webb B, Rizk E, Patel A, Miller PA, Sung SS, Connor JR. Lee SY, et al. PLoS One. 2014 Sep 25;9(9):e108166. doi: 10.1371/journal.pone.0108166. eCollection 2014. PLoS One. 2014. PMID: 25255031 Free PMC article.

10

HFE polymorphisms affect survival of brain tumor patients.

Lee SY, Slagle-Webb B, Sheehan JM, Zhu J, Muscat JE, Glantz M, Connor JR. Lee SY, et al. J Neurooncol. 2015 Mar;122(1):97-104. doi: 10.1007/s11060-014-1681-1. Epub 2014 Dec 10. J Neurooncol. 2015. PMID: 25491948

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27 results

Search Page